and Greg, afternoon, everyone. good Thanks
Before to me today's news we non-GAAP of further supplemental as measures today's started regarding financials, covered you as let Please basis remind on otherwise. unless refer information that with the our financial call noted non-GAAP nuvasive.com get financial the are a well information the for on in earnings release many reconciliations.
reported constant XXXX, of For performance currency growth reflects approximately year-over-year a growth basis. we on million, revenue the performance which reported X% and first X% $XXX quarter
of Excluding revenue an currency. of on XXXX, the SafePassage X% in basis, the organic closed mid-January approximately excluding which our impact impact acquisition, grew
the volume International biologics flat in Our strong legacy impact was a new by results core in the on the business where revenue NuVasive growth expected case offset U.S. XX% essentially decline and volume currency growth business. hardware our were by and and of the business, constant our case introductions in Services of product driven Clinical in weaker basis performance primarily
in revenue this Offsetting of approximately product continued the some area timing introductions the of U.S. primary we case pricing Our year these our revenue new and XLIF for of performance systems. growth expect approximately of The back Hardware of which posterior and gains over Modulus, Spinal quarter, cervical challenges was $XXX.X approximately and from launches the around the in in the were RELINE first X% product primarily centered was that Small X% growth mix Stature, and to half of volume pressure million of see in fixation growth COHERE, XXXX. million. RELINE $XXX.X prior like represents contribution X% drivers TLX,
of from in growth $X.X Additionally, the our we which surgeons in million ongoing to year. was first growth growing contribute our Revenue Revenue expected new services acquisition of NuVasive, which space. the in Early Support to of at are to for we which in and Surgical flat U.S. U.S. existing and strong and line. services of we lower the period the was biologics year. fast first our in a performed the efforts quarter, convert volume first leader case see quarter to weakness services with market same quarter, our the offset by XXXX SafePassage product was prior kind the compared pleased business $XX.X will the SafePassage, throughout demonstrates within available experienced million is acquired business growth from the in current
the that integration led a on-boarded focus in U.S. on business. factor business, our we case our As to was weaker existing contributing volumes services
through As maintaining moving to a the expanding base team, in balancing, customer our thoughtfully focus a integration concurrently, attending while cases and management we are existing on footprint some key process. the
exit be balance moving expect the our to to not accounts our positive to have results new group for margin. accounts the we're resources the first revenue Another this XXXX, that deeper existing was service going in a those momentum into of half year. aggressive driver in into did accounts of strategically of to In stem seen go forward. accounts turn, identified business, see internal chose quarter back biologics in threshold for utilizing and winning profitability we meet more of momentum select from XXXX, losses we and the as our the the business In
meeting retraining our this leadership sales business, with adjusted for we at entire Greg mentioned, year This new sales earlier this across franchise. global yielded biologics competitive be seven with have under and lost efforts positive combined for the recapture to As portfolio. results more offerings accounts force-wide the re-engagement on have
LessRay, in the to growing continue pertains platform. it to As we see interest
we are to trials progresses. is partnership which to as We slightly we more timing revenue behind our as convert targets, the believe firm drive issue of commitments a year
second and currency primarily continued first revenue the impact On still the sixth conditions basis, XX% constant that results EMEA growing are currency market on the America very constant quarter and grew in least performance of in in following been see solid That key Japan, $XX.X in with and basis, performances Our International challenged strong on improve to into consecutive of basis hurricane. Pac Arabia. across as all basis. season. a much strong XX%, Brazil as gains markets expect bad Western UK year-over-year of This that we XX% Europe a offset softness quarter a by difficult in are consecutive year. availability emerging The This the XX% On in Profitability. temporal resulting South doubled constant region. key was continues away and its quarter XLIF limited Africa re-allocated market grew Brazil, sixth infrastructure due the XXXX than quarter prior the we to grew driven a revenue growth a beds Asia strong deliver experienced pleased of On by constant re-introduction Rico hospital the business growth. growth in we the from like market In basis, UK, growth across and spread seen said, the by Puerto business Latin approximately currency dynamic X% the share a lingering that to XX% flu quarter. more to performance reported from elective by strong driven very has pleased has Saudi where the procedures was we were and unusually driven regions. bed at in million, marks and over the currency rate the strength for the of and has delivered
year-over-year gross prior at erosion higher points as primary decline of a a quarter XX.X%. Approximately gross what in attributable below of operating throughput of decline a the experienced of quarter margin decline and the for of expected decline. margin XXX profitability, in was We basis driver XX.X%, our the margin year West XXX that facility. basis to non-GAAP to the result the production and slower ultimately than first Moving was led points to Carrollton our facility
the throughput ramped impacted bottlenecks pertains total Fairborn in of What have migrating of XXXX. quarter been performance we absorption facility end which to level from our end West after output at volumes production the back quarter, up in early of disappointed As it the manufacturing therefore once the had first the with the and in process Carrollton, we found fully had rates.
and We these throughput acceleration increased have issues In the plant fix quarter, level have we first the to since continue and quarter the second the through experienced worked normalize will ramp up. that from year.
around our manufacturing a getting contribution our thesis the are on right to margin while in-sourcing significant and intact, we this make efforts bit future. we our remains Our it believe will improvement and progress, represents while inventory. for the we to a allowing will source the tremendous points XXX us profitability, manufacturing full capacity, When of margin basis improved plant of opportunity get deliver to control behind
on continue focus the beyond. supply of from balance points chain in drivers the resulting deliver of will benefits gross in is the and the will acquisition quarter SafePassage, the of margin Other basis in the to year our We as factory operating offset through XX which ensuring investments decline margin. reminder a included variance
pressure to revenue or XX of expenses SM&A from basis year $XXX.X being margins. XX% prior percent towards operating revenue heavily to the which quarter of International of as have in approximately revenue points plan result of decline generated a weighted mix Our yielded around points decline on XX points the basis a as And million. decreased basis XXX revenue first Non-GAAP of over lastly, related pricing lower year. prior
productivity we Domestically, have International that in to containment. seen overhead continuing our the leverage we With cost efficient the growth are business, of benefit cost. and fixed our scale expanding
expenses research $XX.X revenue, in million manner. an X.X% XX to in quarter first disciplined very continue increase quarter or totaled R&D, in development, which XXXX. was Non-GAAP or points a approximately expenses compared the the We and to basis first of our manage operating of
our R&D R&D of Surgical and have will Materials product past, launches strategic supporting related spend that efforts believe assets results. declared that recent to through platforms. the to clear drive reflects investments and A As increased we both in drive Advanced Intelligence platforms is these we demonstration internal to material innovation. acquired and our in investing We continued commitment in apparent upcoming
of reported we quarter in operating compared profit First quarter XXX to non-GAAP was down points XX.X%, first basis have the margin XX% XXXX.
For the we gross in through manufacturing over our margin from with points margin margin our slower saw offset gross flowed line. West reducing operating related profitability the enough expenses operating We Carrollton, as quarter, of made challenge. primary progress prior throughput pressures which operating not issue the down the was created our facility. to impacting production to basis a at spend Year-over-year, by but year, XXX our percentage revenue to the headwinds
to While margin QX, expansion points performance we XXX delivering year. are in committed we disappointed basis operating our remain of for in the
business continue invest while a driving and to margin improvements will operating and the deliver in in to We prudent increased for margin periods. future approach, both with profitability gross balanced
and further interest certain in investments same This expense a made year. we P&L, from was period increase the result in XXXX. basis $X.X primarily on up was the the non-GAAP other first the net million Moving down $X.X quarter, of in million last equity
from continued benefactor, as significantly pleased tax, States a say, XX.X% which which, to shift expense X,XXX the helps non-GAAP overall the of improvement an tax a to large tax combination year. United reform basis lower rate very rate of of our effective which is prior the the NuVasive rate. is newly resulting tax profitability, more non-GAAP the in This is a of well international reduce as to tax quarter enacted in the was $X.X we're turning million, points in Now than
to from you up had more structure a and As years associated benefit with recall, those to we ago our set shift to see continued benefits International efforts. revenue may tax we
the performance income was year, last year. share earnings discussed. $XX.X was share $X.XX of non-GAAP $XX.X expectations margin First or challenge our per This I the below earnings stemming from previously million or X% of per $X.XX, over to net period compared $X.XX of quarter income same non-GAAP prior an of in net or increase million
to time get as digits We double expect on well. look back the EPS grow growth to trajectory operating non-GAAP margin in into over and the
per results, per impact Adjusted with Please GAAP period of related decrease to last last our was for nuvasive.com to release quarter $XX.X XXXX, was some XX.X% non-GAAP the quarter EBITDA with further $X.XX and margin non-cash refer in combined press in year. compensation share supplemental our or loss or year. file information net compared on GAAP adjustments XX.X% income the the of $XX.X the versus Turning XXXX earnings the the share financial the non-GAAP period year compared million information compensation $X.XX in decrease margin, net for to This stock-based same largely for in first line current million GAAP excludes adjustments. of other to the our the posted year. was same favorability in which in first share-based to operating in the or
$X Finally, compared increase a prior million in period same The XXXX. working free the improvements. negative positive the cash primarily capital was to year driven was over flow by for in $X a quarter million
this related agent. the is information During and liability judgment accrual found an filings. of a to lawsuit we important our approximately our former SEC million appeal is is only for sales still know be that It an More to a in can pending. with $XX accrual the quarter, disclosed of previously litigation recorded
years. to expect and NuVasive also over state. based our tax viewed will be which we're this the in for we a yield ruling specific XX to primary use distribution quarter, locally-based $XXX the the excess of a savings Memphis, the million With state next in in sales, For facility taxes entails entity tax property, subject no government, consideration to Tennessee announcing as longer with the
it we tax our non-recurring, success-based the financials quarter. consulting $X.X of million fee in the a cost specialized this to structure, pertains during recorded for As have
delivering enormous about years the pleased value are We shareholders. upcoming back our this ruling in savings the brings to over
be and remainder first billion guidance, reiterating of outlook the are quarter revenue turning the the range Now in $X.XXX year, $X.XXX results of XXXX for our the to topic of guidance based on to billion. full-year to we for our
exchange XXXX expect and rate up assumptions approximately million, assumptions. from million updated of our is have have positive impact $X a We prior in currency which $XX to
early based this on a contribution alone. is potential While from improvement update in it year in currency the is currency, to expectations modest revenue too
challenge of facility, result margin manufacturing our the profitability adjusting our expense effective that erosion the for through recovering we are guidance in to a As down XX.X% leverage. gross and XX% year profitability from operating
We goal are and for guidance the our margin at year reiterating operating XX.X%.
Our our work will internal plan. be business, portfolio. cost In quarter have been that singularly to in biologics focused on for margin performance by our closing, accelerating our we're and place our the encouraged achieve output the volume hardware XX% our optimizing the from guidance by initiatives in in through achievement of to case our path manufacturing operating facility structure our in first driven momentum and growth the revenue International better-than-expected operating
improvement both ahead plan the As we delivering that, Q&A. margin our operating to confident basis and revenue for for continuing committed the and year. the target Thank on we And open look of remain points with we'll the to call year, balance of XXX you.
